505 related articles for article (PubMed ID: 30411728)
61. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
62. Dual-Energy Computed Tomography-Based Iodine Quantitation for Response Evaluation of Lung Cancers to Chemoradiotherapy/Radiotherapy: A Comparison With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Positron Emission Tomography/Computed Tomography Response Evaluation Criterion in Solid Tumors.
Ren Y; Jiao Y; Ge W; Zhang L; Hua Y; Li C; Zhai W; Tang X; He W; Fang M; Zheng X
J Comput Assist Tomogr; 2018; 42(4):614-622. PubMed ID: 29613988
[TBL] [Abstract][Full Text] [Related]
63. Quantitative evaluation of normal spinal osseous metabolism with 18F-NaF PET/CT.
Ayubcha C; Zirakchian Zadeh M; Stochkendahl MJ; Al-Zaghal A; Hartvigsen J; Rajapakse CS; Raynor W; Werner T; Thomassen A; Zhuang H; Høilund-Carlsen PF; Alavi A
Nucl Med Commun; 2018 Oct; 39(10):945-950. PubMed ID: 30086077
[TBL] [Abstract][Full Text] [Related]
64. First experience with early dynamic (18)F-NaF-PET/CT in patients with chronic osteomyelitis.
Freesmeyer M; Stecker FF; Schierz JH; Hofmann GO; Winkens T
Ann Nucl Med; 2014 May; 28(4):314-21. PubMed ID: 24474597
[TBL] [Abstract][Full Text] [Related]
65.
Suh MS; Park SH; Kim YK; Yun PY; Lee WW
Clin Radiol; 2018 Apr; 73(4):414.e7-414.e13. PubMed ID: 29223613
[TBL] [Abstract][Full Text] [Related]
66. Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept.
Beheshti M; Saboury B; Mehta NN; Torigian DA; Werner T; Mohler E; Wilensky R; Newberg AB; Basu S; Langsteger W; Alavi A
Hell J Nucl Med; 2011; 14(2):114-20. PubMed ID: 21761011
[TBL] [Abstract][Full Text] [Related]
67. Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases.
Simoncic U; Perlman S; Liu G; Staab MJ; Straus JE; Jeraj R
Clin Genitourin Cancer; 2015 Feb; 13(1):e7-e17. PubMed ID: 25128349
[TBL] [Abstract][Full Text] [Related]
68. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR
Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282
[TBL] [Abstract][Full Text] [Related]
69. Impact of Personal Characteristics and Technical Factors on Quantification of Sodium 18F-Fluoride Uptake in Human Arteries: Prospective Evaluation of Healthy Subjects.
Blomberg BA; Thomassen A; de Jong PA; Simonsen JA; Lam MG; Nielsen AL; Mickley H; Mali WP; Alavi A; Høilund-Carlsen PF
J Nucl Med; 2015 Oct; 56(10):1534-40. PubMed ID: 26205304
[TBL] [Abstract][Full Text] [Related]
70. A novel method to assess subchondral bone formation using [18F]NaF-PET in the evaluation of knee degeneration.
Jonnakuti VS; Raynor WY; Taratuta E; Werner TJ; Alavi A; Baker JF
Nucl Med Commun; 2018 May; 39(5):451-456. PubMed ID: 29505483
[TBL] [Abstract][Full Text] [Related]
71. Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET/CT bone scan: a pictorial review.
Sarikaya I; Elgazzar AH; Sarikaya A; Alfeeli M
Nucl Med Commun; 2017 Oct; 38(10):810-819. PubMed ID: 28777220
[TBL] [Abstract][Full Text] [Related]
72. Initial experience with
Usmani S; Marafi F; Esmail A; Ahmed N
Br J Radiol; 2018 Apr; 91(1084):20170741. PubMed ID: 29293370
[TBL] [Abstract][Full Text] [Related]
73.
Papadakis GZ; Manikis GC; Karantanas AH; Florenzano P; Bagci U; Marias K; Collins MT; Boyce AM
J Bone Miner Res; 2019 Sep; 34(9):1619-1631. PubMed ID: 31116487
[TBL] [Abstract][Full Text] [Related]
74. Use of
Jeon TJ; Kim S; Park J; Park JH; Roh EY
BMC Med Imaging; 2018 Sep; 18(1):34. PubMed ID: 30236078
[TBL] [Abstract][Full Text] [Related]
75. Imaging Bone-Cartilage Interactions in Osteoarthritis Using [
Savic D; Pedoia V; Seo Y; Yang J; Bucknor M; Franc BL; Majumdar S
Mol Imaging; 2016 Jan; 15():1-12. PubMed ID: 28654417
[TBL] [Abstract][Full Text] [Related]
76. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
77. Clinical implication of 18F-NaF PET/computed tomography indexes of aortic calcification in coronary artery disease patients: correlations with cardiovascular risk factors.
Ryoo HG; Paeng JC; Koo BK; Cheon GJ; Lee DS; Kang KW
Nucl Med Commun; 2020 Jan; 41(1):58-64. PubMed ID: 31764599
[TBL] [Abstract][Full Text] [Related]
78. Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with
Oliveira-Santos M; Castelo-Branco M; Silva R; Gomes A; Chichorro N; Abrunhosa A; Donato P; Pedroso de Lima J; Pego M; Gonçalves L; Ferreira MJ
Atherosclerosis; 2017 May; 260():41-46. PubMed ID: 28349887
[TBL] [Abstract][Full Text] [Related]
79. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A
Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806
[TBL] [Abstract][Full Text] [Related]
80. Combining 123I-metaiodobenzylguanidine SPECT/CT and 18F-FDG PET/CT for the assessment of brown adipose tissue activity in humans during cold exposure.
Admiraal WM; Holleman F; Bahler L; Soeters MR; Hoekstra JB; Verberne HJ
J Nucl Med; 2013 Feb; 54(2):208-12. PubMed ID: 23318291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
